Clinical Trials Logo

Hearing Loss clinical trials

View clinical trials related to Hearing Loss.

Filter by:

NCT ID: NCT03881514 Completed - Clinical trials for Hearing Loss, Neonatal

Mode of Delivery on Newborn Hearing Test

Start date: January 1, 2017
Phase:
Study type: Observational

Neonatal hearing screening may fail due to some perinatal and neonatal factors. It is well known that false positivity increases cost and maternal anxiety and anxiety in the neonatal hearing screening. The effect of the type of delivery to hearing screening is not yet clear. The first automated mode of delivery of babies born in Turkey auditory brainstem response (SAD's), the authors aimed to evaluate the effects of the test results and false positive rate. newborns were evaluated with brainstem response test. The AABR test was performed before patients were discharged. Perinatal and neonatal variables and AABR test results were recorded retrospectively.

NCT ID: NCT03878875 Completed - Clinical trials for Hearing Loss, Noise-Induced

Does Sound Conditioning Protect Against Temporary Hearing Damage

Start date: January 1, 2020
Phase:
Study type: Observational

This research project will contribute to the research surrounding the effect on the ear after noise exposure. This ever-growing field of research has never been more applicable than now with the increase of recreational noise exposure. Noise is the leading cause of preventable hearing loss and excessive occupational noise along with recreational noise exposure can cause a devastating disability. The World Health Organisation (WHO) estimates 1.1 billion young people could be at risk of hearing loss due to unsafe listening practices. One of the mechanisms that could increase the resistance against noise induced hearing loss is 'sound conditioning'. Animal studies have found that prior exposure to low level noise over a period of a few weeks can 'condition' the ear. This conditioning then reduces the susceptibility to high level exposure i.e. strengthening the ear. In this study, the investigators aim to determine whether previous exposure to loud noise can condition the human ear, reducing the temporary hearing loss and temporary tinnitus ("ringing in the ear") that sometimes occurs after attending a loud nightclub or live music event. There are many implications of this research. For one it will allow us to understand more about the susceptibility to exposure of sounds and the resistance against noise induced hearing loss. This will mean that the investigators can enable appropriate interventions if necessary. For example, individuals who are more susceptible due to low prior exposure may be advised that they are at risk, and encouraged to use hearing protection. Being able to learn more about the impacts of noise with hearing and educate others such as understanding the impacts from high-level exposure.

NCT ID: NCT03875339 Completed - Clinical trials for Congenital Hearing Loss

Communities Helping the Hearing of Infants by Reaching Parents

CHHIRP
Start date: January 13, 2021
Phase: N/A
Study type: Interventional

Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed testing. This research employs a new method for helping children with hearing loss receive timely care by using a patient navigator, who is someone who teaches and provides emotional/social support for the families of these children. The hypothesis of this study is that a patient navigator will hasten the timing of pediatric audiological testing, improve compliance with scheduled appointments, and expand parental knowledge of pediatric hearing loss.

NCT ID: NCT03872882 Completed - Hearing Loss Clinical Trials

Accuscreen Equipment Evaluation For Newborn Hearing Screening

Start date: March 22, 2017
Phase:
Study type: Observational

An evaluation and comparison of results between the 'Accuscreen New' currently in use and an 'Accuscreen New' with different settings to see if the new settings reduce unnecessary referrals for babies from newborn hearing screening. Babies will be tested with the standard and modified equipment. Referrals for diagnostic testing will be based on the standard equipment. A comparison in referrals between the standard and modified equipment will be made.

NCT ID: NCT03867396 Completed - Clinical trials for Hearing Loss, Sensorineural

Evaluation of Speech-in-noise Performance in Cochlear Implant Recipients With a CROS Device on the Contralateral Ear

Start date: January 23, 2019
Phase: N/A
Study type: Interventional

Speech understanding in noise remains the greatest challenge for people using cochlear implants, particularly when the speech of interest comes from the side of the head opposite to the implant. Recent findings in hearing technology allow for people to either use a hearing aid or a Contralateral Routing of Signal (CROS) device on the non-implanted ear. Differences in speech understanding may result depending on the device chosen by a person, and these differences may be measureable through speech discrimination measurement methods. This study intends to determine whether or not a CROS device improves speech perception in noise when the source of the speech of interest originates from the side of the head opposite to the implant.

NCT ID: NCT03864003 Completed - Hearing Loss Clinical Trials

Community Health Workers and Teleaudiology as a Culturally-relevant Approach to Improving Access to Hearing Health Care

Start date: October 30, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to test the feasibility of a teleaudiology intervention with assistance from Community Health Workers to improve access to hearing health care.

NCT ID: NCT03861442 Completed - Hearing Loss Clinical Trials

Front-End Processing 3.0

FEP3
Start date: April 1, 2019
Phase:
Study type: Observational

This study investigated the impact of Automatic Sound Management 3.0 (i.e. ambient noise reduction, transient noise reduction and an adaptive intelligence) as implemented in the SONNET2 on CI users' speech performance and their subjective quality of hearing and device handling.

NCT ID: NCT03850678 Completed - Hearing Loss Clinical Trials

Restoration of Spectral Resolution With Hearing-aid Amplification

Start date: April 2, 2019
Phase: N/A
Study type: Interventional

The objective of this study protocol is to determine the efficacy of using aided measures of spectral resolution to set the dynamic range of hearing with hearing-aid amplification. Measures of spectral resolution will be obtained, as will measures of speech recognition.

NCT ID: NCT03848910 Completed - Clinical trials for Conductive Hearing Loss

Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor

Start date: February 19, 2019
Phase: N/A
Study type: Interventional

The aim of this clinical investigation is to investigate the subject´s overall preference, hearing performance and self-reported assessments with the Investigational device and its precursor Sound Processor (Comparator) after 6 weeks in subjects with conductive/mixed hearing loss or Single Sided Deafness, (SSD).

NCT ID: NCT03834714 Completed - Clinical trials for Hearing Loss, Noise-Induced

Noise Exposure and Near-Infrared Light

Start date: February 18, 2020
Phase: N/A
Study type: Interventional

The primary objective of this work is to determine the effect noise has on the auditory system (both auditory health and performance) and also the degree to which the effect of pre-noise therapy such as Near Infrared (NIR) light can mitigate the effects of noise exposure.